17
PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

Embed Size (px)

Citation preview

Page 1: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

PRP USE IN CARDIOTHORACIC

SURGERY

R. S. KHALAFI, M.D., FACS, FCCP

DIRECTOR,CARDIOTHORACIC SURGERY

NORTH TEX. AFFL. MED GROUP

Page 2: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

Total for Treatment of

One Mediastenitis Case

$235,846.32

Page 3: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

PATIENT PROFILE WITH MEDIASTENITIS

• 48 YEAR OLD WHITE MALE

• HISTORY OF HTN, HYPERLIPIDEMIA

• SMOKING, INSULIN DEPENDENT DIABETES

• SEVERE 3 VESSEL CORONARY ARTERY DISEASE

• PREVIOUS HEART ATTACK

Page 4: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

HOSPITAL COURSE

• UNDERWENT 3 VESSEL BYPASS

• PURULENT DRAINAGE FROM STERNAL WOUND 5 DAYS AFTER THE SURGERY

• UNDERWENT REOPERATION FOR STERNAL DBRIEDEMENT AND CLOSURE

Page 5: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

HOSPITAL COURSE

• REQUIRED 6 WEEKS OF VANCOMYCIN TREATMENT FOR MRSA INFECTION

• 3 WEEKS OF HOSPITALIZATION AND 3 WEEKS OF HOME HEALTH CARE

• REQUIRED 5 WEEKS OF OPEN WOUND DRESSING CHANGES

Page 6: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

MEDIASTINITIS

• INFECTION OF THE STERNUM

• INCIDENCE OF MEDIASTENITIS IS 1-6%

• MOST DEVESTATING POST OPERATIVE COMPLICATION

• REQUIRES MULTIPLE OPERATIONS

• SOMETIMES REQUIRES RESECTION OF THE STERNUM WITH MUSCLE FLAP

Page 7: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

MEDIASTINITIS

Page 8: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

MEDIASTINITIS

• 2% RISK OF INFECTION IS QUOTED TO PATIENTS

• IF NOT DIAGNOSED EARLY WILL LEAD TO DEATH 100% OF THE TIME

Page 9: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

WHY DO I DO IT

• OUT OF 450 CASES LAST YEAR WE HAD 5 MEDIASTINITIS AND NUMEROUS LEG INFECTIONS

• ONE DEATH FROM SEVERE SEPTECEMIA

• TREMENDOUS AMOUNT OF COST • MANY CASES OF CLEAR DRAINAGE

FROM THE WOUNDS

Page 10: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

Technique

•110ml of blood is drawn

•Two GPS disposables are processed- One for the sternum- One for the graft harvest site on

the leg

Page 11: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

After chest wires are put in but before tightening,half of the platelet rich plasma (PRP) is sprayed along the exposed sternal edges.

Page 12: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

The wires are then tightened and the remaining PRP is sprayed over the subcutaneous tissue.

Page 13: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

Platelet Poor Plasma (PPP) is then applied to each layer upon closure. Leave PPP is place and sew through PPP gel. Do not lap up after applying.

Page 14: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

Platelet Rich Plasma (PRP) is delivered through a long, dual cannula and backfilled along the graft harvest site.

PRP Application

Page 15: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

After applying Platelet Rich Plasma (PRP) to the leg, apply the Platelet Poor Plasma (PPP) in the same fashion with a long, dual cannula tip.

PPP Application

Page 16: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

RESULTS

• 700 CASES TO DATE

• ONE CASE OF MEDIASTINITIS AND ONE LEG INFECTION

• RAPID WOUND HEALING

• EXTREMELY SMALL NUMBER WITH WOUND DRAINAGE

Page 17: PRP USE IN CARDIOTHORACIC SURGERY R. S. KHALAFI, M.D., FACS, FCCP DIRECTOR,CARDIOTHORACIC SURGERY NORTH TEX. AFFL. MED GROUP

THANK YOU